Pharmacomicrobiomics - Another Frontier of Precision Medicine

Overview

Journal Indian J Pharmacol

Specialty Pharmacology

Date 2024 Sep 9

PMID 39250619

Authors

Santenna Chenchula

Shubham Atal

Anusuya Bhattacharyya

Bikash Medhi

Madhavrao Chavan

Phulen Sarma

Affiliations

Soon will be listed here.

References

Chenchula S, Sharma P, Ghanta M, Amerneni K, Rajakarunakaran P, Saggurthi P . Association and Mechanisms of Proton Pump Inhibitors Use with Type-2Diabetes Mellitus Incidence in Adults: A Systemic Review andMeta-Analysis. Curr Diabetes Rev. 2024; 20(10):e120124225581. DOI: 10.2174/0115733998254869231101095222. View

Dikeocha I, Al-Kabsi A, Miftahussurur M, Alshawsh M . Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism. FASEB J. 2022; 36(6):e22350. DOI: 10.1096/fj.202101986R. View

Vich Vila A, Collij V, Sanna S, Sinha T, Imhann F, Bourgonje A . Impact of commonly used drugs on the composition and metabolic function of the gut microbiota. Nat Commun. 2020; 11(1):362. PMC: 6969170. DOI: 10.1038/s41467-019-14177-z. View

Anitha K , Singh M, Kohat K, Sri Varshini T , Chenchula S, Padmavathi R . Recent Insights into the Neurobiology of Alzheimer's Disease and Advanced Treatment Strategies. Mol Neurobiol. 2024; 62(2):2314-2332. DOI: 10.1007/s12035-024-04384-1. View

Mohamed M, Saqr A, Staley C, Onyeaghala G, Teigen L, Dorr C . Pharmacomicrobiomics: Immunosuppressive Drugs and Microbiome Interactions in Transplantation. Transplantation. 2024; 108(9):1895-1910. PMC: 11327386. DOI: 10.1097/TP.0000000000004926. View

Conti G, DAmico F, Fabbrini M, Brigidi P, Barone M, Turroni S . Pharmacomicrobiomics in Anticancer Therapies: Why the Gut Microbiota Should Be Pointed Out. Genes (Basel). 2023; 14(1). PMC: 9859289. DOI: 10.3390/genes14010055. View

Chen H, Gong J, Xing K, Liu M, Ren H, Luo J . Pharmacomicrobiomics: Exploiting the Drug-Microbiota Interactions in Antihypertensive Treatment. Front Med (Lausanne). 2022; 8:742394. PMC: 8808336. DOI: 10.3389/fmed.2021.742394. View

Minichino A, Preston T, Fanshawe J, Fusar-Poli P, McGuire P, Burnet P . Psycho-Pharmacomicrobiomics: A Systematic Review and Meta-Analysis. Biol Psychiatry. 2023; 95(7):611-628. DOI: 10.1016/j.biopsych.2023.07.019. View

Torres-Carrillo N, Martinez-Lopez E, Torres-Carrillo N, Lopez-Quintero A, Moreno-Ortiz J, Gonzalez-Mercado A . Pharmacomicrobiomics and Drug-Infection Interactions: The Impact of Commensal, Symbiotic and Pathogenic Microorganisms on a Host Response to Drug Therapy. Int J Mol Sci. 2023; 24(23). PMC: 10707377. DOI: 10.3390/ijms242317100. View

10.

Chrysostomou D, Roberts L, Marchesi J, Kinross J . Gut Microbiota Modulation of Efficacy and Toxicity of Cancer Chemotherapy and Immunotherapy. Gastroenterology. 2022; 164(2):198-213. DOI: 10.1053/j.gastro.2022.10.018. View

11.

Kazmierczak-Siedlecka K, Bulman N, Ulasinski P, Sobocki B, Polom K, Marano L . Pharmacomicrobiomics of cell-cycle specific anti-cancer drugs - is it a new perspective for personalized treatment of cancer patients?. Gut Microbes. 2023; 15(2):2281017. PMC: 10730203. DOI: 10.1080/19490976.2023.2281017. View

12.

Cox L, Kuchroo V . Autoimmunity and the microbiome. Immunol Rev. 2024; 325(1):4-8. DOI: 10.1111/imr.13363. View

13.

Wang X, Yuan W, Yang C, Wang Z, Zhang J, Xu D . Emerging role of gut microbiota in autoimmune diseases. Front Immunol. 2024; 15:1365554. PMC: 11099291. DOI: 10.3389/fimmu.2024.1365554. View

14.

Zhao Q, Chen Y, Huang W, Zhou H, Zhang W . Drug-microbiota interactions: an emerging priority for precision medicine. Signal Transduct Target Ther. 2023; 8(1):386. PMC: 10560686. DOI: 10.1038/s41392-023-01619-w. View

15.

Levy C, Goldman P . The enzymatic hydrolysis of methotrexate and folic acid. J Biol Chem. 1967; 242(12):2933-8. View

16.

Brown L, Bobo W, Gall C, Muller D, Bousman C . Pharmacomicrobiomics of Antidepressants in Depression: A Systematic Review. J Pers Med. 2023; 13(7). PMC: 10381387. DOI: 10.3390/jpm13071086. View

17.

Wang S, Ju D, Zeng X . Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era. Biomedicines. 2024; 12(1). PMC: 10813426. DOI: 10.3390/biomedicines12010194. View

18.

Aggarwal N, Kitano S, Puah G, Kittelmann S, Hwang I, Chang M . Microbiome and Human Health: Current Understanding, Engineering, and Enabling Technologies. Chem Rev. 2022; 123(1):31-72. PMC: 9837825. DOI: 10.1021/acs.chemrev.2c00431. View

19.

Chenchula S, Atal S, Uppugunduri C . A review of real-world evidence on preemptive pharmacogenomic testing for preventing adverse drug reactions: a reality for future health care. Pharmacogenomics J. 2024; 24(2):9. PMC: 10942860. DOI: 10.1038/s41397-024-00326-1. View